Vertex Pharmaceuticals Incorporated (LON: 0QZU)
London
· Delayed Price · Currency is GBP · Price in USD 460.47
+18.33 (4.15%)
At close: Jan 31, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 95.65 billion as of January 31, 2025. Its market cap has increased by 8.39% in one year.
Market Cap
95.65B
Enterprise Value
88.05B
Revenue
7.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
460.47
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 95.65B, an increase of 186,680.63%. That is a compound annual growth rate of 25.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.89B |
| GSK plc | 57.33B |
| Haleon | 33.92B |
| Smith & Nephew | 9.00B |
| Hikma Pharmaceuticals | 5.08B |
| ConvaTec Group | 5.06B |
| HUTCHMED (China) | 1.88B |
| Oxford Nanopore Technologies | 1.39B |